A Pharmacodynamic and Pharmacokinetic Study of RO5508887 in Healthy Volunteers

Summary

This randomized, double-blind, placebo-controlled, parallel group study will evaluate the pharmacodynamics and pharmacokinetics of RO5508887 in healthy volunteers. Subjects will be randomized in cohorts to receive single oral doses of either RO5508887 or placebo. In-unit period is 6 days.

Timeline

Start

2012-05

Primary completion

2012-10

Completion

2012-10

Drugs

Indications

No indication recorded.